Nanomedicine-Mediated Immunotherapy for Cancer Treatment
- 11 March 2026
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 12 (4) , 1968-1990
Abstract
Since the dawn of the 21st century, the convergence of interdisciplinary fields─including life sciences, nanotechnology, and information technology─propels pharmaceuticals and healthcare into a period of rapid transformation. This paradigm shift catalyzes the emergence of innovative medical technologies. Immuno-oncology plays a pivotal role in cancer therapeutics. However, most patients derive limited benefits from currently available immunotherapies, while many experience immune-related adverse events (irAEs). Consequently, significant research efforts focus on developing nanomedicines that attenuate immunosuppression within the tumor microenvironment (TME) or enhance immune-cell-mediated tumor recognition and cytotoxicity. This review outlines nanomedicine-mediated immunotherapeutic strategies against tumors. Such novel approaches function as monotherapies or synergize with conventional oncology treatments to achieve superior therapeutic outcomes. Nanomedicine offers a transformative framework for precision cancer therapy through rational design principles that integrate tumor-specific characteristics and in vivo kinetics of drug transport. These advances hold promise for augmenting existing treatments and expanding therapeutic options for cancer patients. Finally, we critically analyze current challenges and depict the future directions in nanomedicine-driven immunotherapy, aiming to harness the immune system effectively against malignancies and ultimately expand the oncologist’s armamentarium.Keywords
Funding Information
- National Natural Science Foundation of China (51971029)
- National Natural Science Foundation of China (52471259)
This publication has 217 references indexed in Scilit:
- Nanomedicine2024
- A Lysosome‐Targeted Magnetic Nanotorquer Mechanically Triggers Ferroptosis for Breast Cancer TreatmentAdvanced Science, 2023
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent GlioblastomaJAMA Oncology, 2022
- Gadolinium–Rose Bengal Coordination Polymer Nanodots for MR‐/Fluorescence‐Image‐Guided Radiation and Photodynamic TherapyAdvanced Materials, 2020
- Smart Supramolecular “Trojan Horse”‐Inspired Nanogels for Realizing Light‐Triggered Nuclear Drug Influx in Drug‐Resistant Cancer CellsAdvanced Functional Materials, 2019
- Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant NanomaterialsAdvanced Materials, 2018
- Surface Charge Switchable Nanoparticles Based on Zwitterionic Polymer for Enhanced Drug Delivery to TumorAdvanced Materials, 2012
- Microsecond and nanosecond electric pulses in cancer treatmentsBioelectromagnetics, 2011
- Enzyme‐Responsive Nanoparticle SystemsAdvanced Materials, 2008
- Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.The EMBO Journal, 1992